Global Dry Eye Drugs market will register a 11.8% CAGR in terms of revenue, the market size will reach USD 9.33 Billion by 2024, from USD 5.35 Billion in 2019.
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
The classification of Dry Eye Drugs includes Artificial Tears, Anti-inflammatory drugs and other, and the proportion of Artificial Tears in 2017 is about 89%.
North America is the largest consumption place, with a consumption market share nearly 40% in 2017. Following North America, Asia Pacific is the second largest consumption place with the consumption market share of 25%.
According to this study, over the next five years the Dry Eye Drugs market will register a 11.8% CAGR in terms of revenue, the global market size will reach US$ 9330 million by 2024, from US$ 5350 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Dry Eye Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Dry Eye Drugs market by product type, application, key manufacturers and key regions and countries.
This study considers the Dry Eye Drugs value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Artificial Tears
Anti-inflammatory Drugs
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Drug Stores
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Allergan
Novartis AG
Valeant Pharmaceuticals
Santen Pharma
Shire
Johnson & Johnson
United Laboratories
Senju Pharmaceutical
Jianfeng Group
Eusan GMBH
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Dry Eye Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Dry Eye Drugs market by identifying its various subsegments.
Focuses on the key global Dry Eye Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Dry Eye Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Dry Eye Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hrs) post payment.
Table of Contents
2019-2024 Global Dry Eye Drugs Consumption 麻豆原创 Report
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 麻豆原创 Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Dry Eye Drugs Consumption 2014-2024
2.1.2 Dry Eye Drugs Consumption CAGR by Region
2.2 Dry Eye Drugs Segment by Type
2.2.1 Artificial Tears
2.2.2 Anti-inflammatory Drugs
2.2.3 Other
2.3 Dry Eye Drugs Consumption by Type
2.3.1 Global Dry Eye Drugs Consumption 麻豆原创 Share by Type (2014-2019)
2.3.2 Global Dry Eye Drugs Revenue and 麻豆原创 Share by Type (2014-2019)
2.3.3 Global Dry Eye Drugs Sale Price by Type (2014-2019)
2.4 Dry Eye Drugs Segment by Application
2.4.1 Hospital
2.4.2 Drug Stores
2.4.3 Online Pharmacies
2.5 Dry Eye Drugs Consumption by Application
2.5.1 Global Dry Eye Drugs Consumption 麻豆原创 Share by Application (2014-2019)
2.5.2 Global Dry Eye Drugs Value and 麻豆原创 Share by Application (2014-2019)
2.5.3 Global Dry Eye Drugs Sale Price by Application (2014-2019)
3 Global Dry Eye Drugs by Players
3.1 Global Dry Eye Drugs Sales 麻豆原创 Share by Players
3.1.1 Global Dry Eye Drugs Sales by Players (2017-2019)
3.1.2 Global Dry Eye Drugs Sales 麻豆原创 Share by Players (2017-2019)
3.2 Global Dry Eye Drugs Revenue 麻豆原创 Share by Players
3.2.1 Global Dry Eye Drugs Revenue by Players (2017-2019)
3.2.2 Global Dry Eye Drugs Revenue 麻豆原创 Share by Players (2017-2019)
3.3 Global Dry Eye Drugs Sale Price by Players
3.4 Global Dry Eye Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Dry Eye Drugs Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Dry Eye Drugs Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Dry Eye Drugs by Regions
4.1 Dry Eye Drugs by Regions
4.1.1 Global Dry Eye Drugs Consumption by Regions
4.1.2 Global Dry Eye Drugs Value by Regions
4.2 Americas Dry Eye Drugs Consumption Growth
4.3 APAC Dry Eye Drugs Consumption Growth
4.4 Europe Dry Eye Drugs Consumption Growth
4.5 Middle East & Africa Dry Eye Drugs Consumption Growth
5 Americas
5.1 Americas Dry Eye Drugs Consumption by Countries
5.1.1 Americas Dry Eye Drugs Consumption by Countries (2014-2019)
5.1.2 Americas Dry Eye Drugs Value by Countries (2014-2019)
5.2 Americas Dry Eye Drugs Consumption by Type
5.3 Americas Dry Eye Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Dry Eye Drugs Consumption by Countries
6.1.1 APAC Dry Eye Drugs Consumption by Countries (2014-2019)
6.1.2 APAC Dry Eye Drugs Value by Countries (2014-2019)
6.2 APAC Dry Eye Drugs Consumption by Type
6.3 APAC Dry Eye Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Dry Eye Drugs by Countries
7.1.1 Europe Dry Eye Drugs Consumption by Countries (2014-2019)
7.1.2 Europe Dry Eye Drugs Value by Countries (2014-2019)
7.2 Europe Dry Eye Drugs Consumption by Type
7.3 Europe Dry Eye Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Dry Eye Drugs by Countries
8.1.1 Middle East & Africa Dry Eye Drugs Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Dry Eye Drugs Value by Countries (2014-2019)
8.2 Middle East & Africa Dry Eye Drugs Consumption by Type
8.3 Middle East & Africa Dry Eye Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 麻豆原创 Challenges and Impact
9.3 麻豆原创 Trends
10 麻豆原创ing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Dry Eye Drugs Distributors
10.3 Dry Eye Drugs Customer
11 Global Dry Eye Drugs 麻豆原创 Forecast
11.1 Global Dry Eye Drugs Consumption Forecast (2019-2024)
11.2 Global Dry Eye Drugs Forecast by Regions
11.2.1 Global Dry Eye Drugs Forecast by Regions (2019-2024)
11.2.2 Global Dry Eye Drugs Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States 麻豆原创 Forecast
11.3.2 Canada 麻豆原创 Forecast
11.3.3 Mexico 麻豆原创 Forecast
11.3.4 Brazil 麻豆原创 Forecast
11.4 APAC Forecast by Countries
11.4.1 China 麻豆原创 Forecast
11.4.2 Japan 麻豆原创 Forecast
11.4.3 Korea 麻豆原创 Forecast
11.4.4 Southeast Asia 麻豆原创 Forecast
11.4.5 India 麻豆原创 Forecast
11.4.6 Australia 麻豆原创 Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany 麻豆原创 Forecast
11.5.2 France 麻豆原创 Forecast
11.5.3 UK 麻豆原创 Forecast
11.5.4 Italy 麻豆原创 Forecast
11.5.5 Russia 麻豆原创 Forecast
11.5.6 Spain 麻豆原创 Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt 麻豆原创 Forecast
11.6.2 South Africa 麻豆原创 Forecast
11.6.3 Israel 麻豆原创 Forecast
11.6.4 Turkey 麻豆原创 Forecast
11.6.5 GCC Countries 麻豆原创 Forecast
11.7 Global Dry Eye Drugs Forecast by Type
11.8 Global Dry Eye Drugs Forecast by Application
12 Key Players Analysis
12.1 Allergan
12.1.1 Company Details
12.1.2 Dry Eye Drugs Product Offered
12.1.3 Allergan Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Allergan News
12.2 Novartis AG
12.2.1 Company Details
12.2.2 Dry Eye Drugs Product Offered
12.2.3 Novartis AG Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Novartis AG News
12.3 Valeant Pharmaceuticals
12.3.1 Company Details
12.3.2 Dry Eye Drugs Product Offered
12.3.3 Valeant Pharmaceuticals Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Valeant Pharmaceuticals News
12.4 Santen Pharma
12.4.1 Company Details
12.4.2 Dry Eye Drugs Product Offered
12.4.3 Santen Pharma Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Santen Pharma News
12.5 Shire
12.5.1 Company Details
12.5.2 Dry Eye Drugs Product Offered
12.5.3 Shire Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Shire News
12.6 Johnson & Johnson
12.6.1 Company Details
12.6.2 Dry Eye Drugs Product Offered
12.6.3 Johnson & Johnson Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Johnson & Johnson News
12.7 United Laboratories
12.7.1 Company Details
12.7.2 Dry Eye Drugs Product Offered
12.7.3 United Laboratories Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 United Laboratories News
12.8 Senju Pharmaceutical
12.8.1 Company Details
12.8.2 Dry Eye Drugs Product Offered
12.8.3 Senju Pharmaceutical Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Senju Pharmaceutical News
12.9 Jianfeng Group
12.9.1 Company Details
12.9.2 Dry Eye Drugs Product Offered
12.9.3 Jianfeng Group Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Jianfeng Group News
12.10 Eusan GMBH
12.10.1 Company Details
12.10.2 Dry Eye Drugs Product Offered
12.10.3 Eusan GMBH Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Eusan GMBH News
13 Research Findings and Conclusion
听
听
*If Applicable.